PLoS ONE (Jan 2012)

Automated reporter quantification in vivo: high-throughput screening method for reporter-based assays in zebrafish.

  • Steven L Walker,
  • Junko Ariga,
  • Jonathan R Mathias,
  • Veena Coothankandaswamy,
  • Xiayang Xie,
  • Martin Distel,
  • Reinhard W Köster,
  • Michael J Parsons,
  • Kapil N Bhalla,
  • Meera T Saxena,
  • Jeff S Mumm

DOI
https://doi.org/10.1371/journal.pone.0029916
Journal volume & issue
Vol. 7, no. 1
p. e29916

Abstract

Read online

Reporter-based assays underlie many high-throughput screening (HTS) platforms, but most are limited to in vitro applications. Here, we report a simple whole-organism HTS method for quantifying changes in reporter intensity in individual zebrafish over time termed, Automated Reporter Quantification in vivo (ARQiv). ARQiv differs from current "high-content" (e.g., confocal imaging-based) whole-organism screening technologies by providing a purely quantitative data acquisition approach that affords marked improvements in throughput. ARQiv uses a fluorescence microplate reader with specific detection functionalities necessary for robust quantification of reporter signals in vivo. This approach is: 1) Rapid; achieving true HTS capacities (i.e., >50,000 units per day), 2) Reproducible; attaining HTS-compatible assay quality (i.e., Z'-factors of ≥0.5), and 3) Flexible; amenable to nearly any reporter-based assay in zebrafish embryos, larvae, or juveniles. ARQiv is used here to quantify changes in: 1) Cell number; loss and regeneration of two different fluorescently tagged cell types (pancreatic beta cells and rod photoreceptors), 2) Cell signaling; relative activity of a transgenic Notch-signaling reporter, and 3) Cell metabolism; accumulation of reactive oxygen species. In summary, ARQiv is a versatile and readily accessible approach facilitating evaluation of genetic and/or chemical manipulations in living zebrafish that complements current "high-content" whole-organism screening methods by providing a first-tier in vivo HTS drug discovery platform.